Argent Biopharma (AU:RGT) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Argent BioPharma has announced successful resolutions at their General Meeting, with all motions carried. The company is moving forward with plans to shift its listing from the Secondary Listing to the Commercial Companies category, subject to the appointment of a sponsor and FCA approval. Shareholders have also provided the necessary approval for an eventual delisting from the ASX, contingent on the successful transition of listing categories.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
